David Annis
Chief Tech/Sci/R&D Officer at AILERON THERAPEUTICS, INC.
Net worth: 2 500 $ as of 31/03/2024
Profile
David Allen Annis is currently the Senior Vice President-Research at Aileron Therapeutics, Inc. He previously worked as the Director-Technology Development at Schering-Plough Research Institute and as the Vice President-New Technologies at NeoGenesis Pharmaceuticals, Inc. Dr. Annis received his graduate and doctorate degrees from Harvard University and his undergraduate degree from Georgia Institute of Technology.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
30/11/2023 | 377 ( 0.01% ) | 2 500 $ | 31/03/2024 |
David Annis active positions
Companies | Position | Start |
---|---|---|
AILERON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05/11/2018 |
Former positions of David Annis
Companies | Position | End |
---|---|---|
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Corporate Officer/Principal | - |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Training of David Annis
Harvard University | Doctorate Degree |
Georgia Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
AILERON THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
- Stock Market
- Insiders
- David Annis